Objective: Cigarette smoking is a risk factor for earlier menopause. Animal studies show that in-utero smoke exposure is toxic to developing ovaries. Our aim was to evaluate whether in-utero smoke exposed women reach menopause earlier compared with nonexposed women.
M enopause occurs when the ovarian follicle pool is depleted to a minimum threshold. 1 The depletion of these follicles is a process that starts before birth and it continues until menopause. 2 The ovarian reserve, that is, the population of nongrowing follicles (NGF), is established prenatally; at 20 weeks postconception the population of NGF reaches a peak size 3 and some studies suggest that age at menopause is linked to the size of this initial cohort of NGF. 4, 5 As this follicle pool is prenatally determined, early life events that are harmful to germ cells can diminish the initial finite follicle pool a woman is born with 6 and thus might influence timing of menopause.
Women who are smokers reach menopause approximately 1 year earlier compared with nonsmokers. 7, 8 Components of cigarette smoke, such as polycyclic aromatic hydrocarbons (PAHs) and cadmium are involved in pathways leading to follicle loss, either via aryl hydrocarbon receptors in granulosa cells 9 or via inhibition of gap-junctions of oocytes and granulosa cells. 10 Female germ cells are regarded to be especially vulnerable to cigarette smoke exposure during critical periods of primordial follicle development, when mitotic divisions of oogonia occur. 11 Mice pups whose pregnant mothers were nasally exposed to mainstream cigarette smoke during pregnancy showed half the number of primordial and primary follicles when compared with controls. 12 In human, 29 fetal ovaries obtained after legal abortions (aged 38-64 d postconception), in-utero smoke exposure was associated with a nonsignificant decrease in the number of oogonias. 13 These studies suggest that women who are in-utero exposed to cigarette smoke are born with a smaller ovarian reserve compared with nonexposed women, and therefore, might exhaust their follicle pool quicker, reaching menopause earlier.
However, epidemiological studies have not indisputably confirmed nor rejected this hypothesis. Therefore, this study aimed to determine whether there is an association between in-utero smoke exposure and age at menopause in a longitudinal cohort of women whose menopause age was assessed 18 years after entry in the study. We have hypothesized that in-utero smoke exposed women reach menopause earlier compared with unexposed women.
MATERIALS AND METHODS Participants
This is a cohort study within the ongoing Avon Longitudinal Study of Parents and Children (ALSPAC) cohort, which was designed to identify environmental and genetic characteristics that can influence health and development in parents and children. [14] [15] [16] Pregnant women (participants), residents of the Avon County, the United Kingdom, expected to deliver between April 1, 1991 and December 31, 1992, were included in the study. Participant's characteristics for the current analyses were obtained from obstetrical records and from repeated annual follow-up questionnaires. Initially, 14,541 pregnant women (approximately 90% of pregnancies in the study area for enrollment period) were enrolled in the study. In 2010, 18 years after inclusion in the study, questionnaires were sent to 9,028 participants who were still active in the cohort; 4,175 (46.2%) of them returned the questionnaires and these participants were used in the present study. The main risk factor, in-utero smoke exposure, was obtained from questionnaires at baseline. Participants were asked ''did your mother smoke?'' and ''did your mother smoke when pregnant of you (participant)?'' and participants could answer in three different ways: ''yes'', ''no,'' and ''I don't know.'' These questions were asked of participants again 8 years later. To evaluate misclassification and recall bias for in-utero smoke exposure, two analyses were performed. The first analysis evaluated whether in-utero smoke exposed women were born with a lower birth weight compared with women who were not exposed. The second analysis compared answers for in-utero smoke exposure given by the participants for two time points: at enrolment and 8 years later. Menopause status was obtained from questionnaires sent 18 years after baseline. Participants were asked: ''in the last 12 months, have you had a period or menstrual bleeding?'' and ''what was your age at last menstrual bleeding? Please note that the study website contains details of all the data that are available through a fully searchable data dictionary available at http://www.bris. ac.uk/alspac/researchers/data-access/data-dictionary. Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees available at http://www.bristol.ac.uk/alspac/researchers/ research-ethics.
Statistical analysis
Participants with inconsistent or missing information on age at surgery, start of hormone therapy (HT) use, or no age at oncological treatment (postmenopausal due to chemotherapy or radiotherapy) were excluded. Participants who reported ''other reasons'' for menopause in the questionnaire were excluded. Participants with a history of ever using HT or having ovarian/uterine surgical removal before natural menopause were censored at the age of the event. Premenopausal women using HT were also censored at age when they started treatment. For participants who reported being postmenopausal but did not provide age at last menstrual bleeding, age at natural menopause was calculated from age at completion of the questionnaire minus 1 year.
Differences in characteristics of participants who were inutero exposed and participants who were not exposed were tested using unpaired Student's t test, Mann-Whitney U test, or chi-square tests as appropriate. Cox proportional hazards modeling was used to estimate the crude and adjusted effect of in-utero smoke exposure on the age at menopause. Results were adjusted for factors associated with both in-utero smoke exposure and age at menopause. Factors that were different between groups but not associated with age at menopause were not included in the adjusted analyses. A hazard ratio (HR) higher than 1 indicates that in-utero smoke exposure is associated with a higher probability of reaching menopause compared with nonexposed during any given time period. Violation of the proportional hazards assumption was evaluated with Schoenfeld residuals test and the assumption was met (P ¼ 0.40).
Body mass index (BMI) included in the analyses was assessed at the enrolment period. Data analyzed on participants' smoking history included exposure by paternal and/or partner smoking and smoking of participants themselves. Smoking habits of participants were quantified by pack years using data from the follow-up questionnaires (18 assessments in total). Exposure years were calculated by subtracting the age at the assessment point from the age when the participant started smoking. This number was multiplied by the number of cigarettes smoked per day divided by number of cigarettes per pack ([age at assessment point-age started smoking] Â [number of cigarettes per day]/20). This was performed for each questionnaire interval and summed up. Participants were then categorized into heavy smokers (>25 pack y), moderate (>10 and 25 pack y), light ( 10 pack y) and nonsmokers. At time point 18 years after enrolment, participants were asked if they are smokers. Those who answered ''yes'' were classified as current smokers. Previous smokers are the noncurrent smokers with pack years different from zero. Never smokers are participants with zero pack years. Ever smokers include participants who are current or previous smokers.
To verify a possible interaction between smoking habit of participants and in-utero smoke exposure, an interaction term was created with the product term from these two factors (in-utero smoke exposure and smoking of participants themselves), including pack years as a continuous factor. The participants were then stratified into four groups: exposed inutero and ever smoker, exposed in-utero and nonsmoker, not exposed in-utero and ever smoker, and not exposed in-utero and nonsmoker. The latter served as the reference group.
RESULTS
From the questionnaires available, 4,132/4,175 participants provided information on menopause status. There were 7 participants missing data, 36 duplicates participants (twin pregnancies) and 3,515 participants were eligible for analysis after exclusions (Fig. 1) . Out of these, 663/3,515 (18.9%) had missing information about in-utero smoke exposure; 483/663 answered ''I don't know'' and 180/663 did not answer the question. There were 2,157/2,852 (75.6%) premenopausal women and 695/2,852 (24.4%) postmenopausal women. Natural menopause was reported by 466/695 (67.1%) participants of which 359/466 (77.0%) did not provide age at menopause; 112/695 (16.1%) participants had surgical menopause and 117/695 (16.8%) participants used HT. Participants who reported menopause due to other reasons were excluded. Women with missing information on age at surgery and/or start of HT or no age at oncological treatment (postmenopausal due to chemotherapy or radiotherapy) were excluded ( Fig. 1) .
For the participants who had surgery before menopause, 39 participants had hysterectomy and bilateral oophorectomy, 51 had hysterectomy, 6 had hysterectomy and unilateral oophorectomy, 2 had bilateral oophorectomy, and 14 had unilateral oophorectomy.
The kappa level of agreement comparing answers from inutero smoke exposure for two time points (at enrollment and 8 years later, n ¼ 1,032) was 0.91 (p-value 0.001) and there was a disagreement of 5% between answers. Table 1 shows characteristics of the participants. Of all participants, 20.2% (577/2,852) were smoke exposed in-utero and 79.8% (2,775/2,852) were not exposed. In-utero smoke exposed participants were born with a significantly lower birth weight. Compared with participants who were not exposed, participants who were exposed in-utero were younger at the time point 18 years after enrollment, had a higher BMI, were younger when they started using oral contraceptives (OC), and when they had their first pregnancy. There were more current and previous smokers among exposed participants and there was higher passive smoke exposure due to smoking of fathers and partners. In-utero exposed participants also started smoking at a younger age compared with unexposed participants. Table 2 shows HRs for menopause obtained from univariate analyses. A shorter cycle length, a younger age at start of OC, a younger age at first pregnancy, and having had ART were associated with earlier menopause. Being a smoker was associated with earlier menopause as were a younger age at start of smoking and being a heavy smoker.
Analyses were adjusted for factors associated with both inutero exposure and age at menopause (pack years, age at OC use start, age at first pregnancy, and participant's age). Pack years was removed from the adjusted model when other characteristics associated with active smoking of the participants were being analyzed to avoid double correction for smoking factors (see Supplementary Table 3 shows crude and adjusted HR for participants who were in-utero exposure, ever smokers, and for stratified groups of in-utero exposure and ever smoking combined. In-utero smoke exposure was not associated with earlier menopause. There was an interaction between in-utero smoke exposure and pack years of participants (P ¼ 0.02). The stratified analysis confirmed a stronger effect of ever smoking and in-utero exposure on age at menopause, that is smokers who had been exposed in-utero had higher risk when compared with smokers or smokers who were not exposed.
Sensitivity analysis with participants with available age at menopause only did not change the results (HR 0.98, 95% CI 0.75-1.29; adjusted HR 0.97, 95% CI 0.73-1.29; see Supplementary Table 1 , http://links.lww.com/MENO/A250).
Participants were not included in the analyses for two reasons: missing data on in-utero exposure (n ¼ 663) and excluded participants due to other reasons (n ¼ 617). There were no statistically significant differences regarding smoking status between participants who had available (26.2%, 746/ 2,852) and those who had missing data (28.2%, 187/663) regarding in-utero exposure (P ¼ 0.49). For the group who was excluded for other reasons, smoking status was slightly higher (31.9%, 197/617 vs 26.5%, 933/3,515, P ¼ 0.004) as well as in-utero exposure (24.6%, 122/495 vs 20.2%, 577/2,852, P ¼ 0.03). Analysis including these participants (n ¼ 3,347) showed no substantial difference (odds ratio [OR] 0.91, 95% CI 0.76-1.08, adjusted OR 0.86, 95% CI 0.70-1.04) compared with the analysis excluding this group (Table 3) .
DISCUSSION
Results from the present study indicate that in-utero smoke exposure is not associated with earlier age at menopause. There was an interaction between pack years of participants and in-utero smoke exposure, that is, the effect of in-utero smoke exposure was modified by the smoking habits of the participants themselves.
Strengths of this study are the large number of participants and the substantial proportion of postmenopausal women. Moreover, the 18-year follow-up, the availability of repeated questionnaires, and information regarding various factors relevant for the risk of menopause are strong points. This allowed the calculation of pack years for participants who were ever smokers, so that the confounding effect of smoking of participants could be analyzed in a dose-response manner. Forty-two women were premenopausal and using HT. These participants are censored at the age they started using HT or age at surgery.
IN-UTERO SMOKE EXPOSURE AND AGE AT MENOPAUSE
Although there is no previous data available reporting the accuracy of in-utero smoke exposure based on questionnaires, in this data participants who reported being in-utero smoke exposed had a lower birth weight and the agreement between questionnaire from two different time points was satisfactory. This indicates low misclassification and recall bias.
Limitations included no information about the number of cigarettes smoked by the mothers while they were pregnant with the participants, no information about trimester of exposure, and incomplete information on age at menopause. Higher levels of in-utero smoke exposure could have an effect on age at menopause, similar to the dose-effect relationship observed for the smoking habits during adulthood. Given the time period during which these pregnancies occurred, that is around the mid-1960s, we assumed mothers of the participants would have smoked during the entire pregnancy. Smoking was widely accepted in this period 17 and the effects of smoking during pregnancy were not widely known. 18 In the present study, we had to estimate age at menopause by subtracting 1 year of the questionnaire's age at completion for 51.7% (359/695) of participants who reported they were postmenopausal. This may have resulted in shifting age at menopause to a later age for women who went into menopause more than 1 year before completion of the questionnaire. Nevertheless, analysis including only participants with available age at menopause showed a similar effect compared with the analysis including women whose age at menopause was estimated. 
HONORATO ET AL
The long follow-up period resulted in a dropout rate of 38% (5,513/14,541) and there was a response rate of 46.2% (4,175/ 9,028), when considering participants who were still active in the cohort. Therefore, our results are based on 20% (2,852/ 15,541) of the original data, from which results cannot be extended and as consequence we cannot exclude the risk of selection bias. 19 Participants in this study were pregnant when they were recruited. Therefore, results cannot be readily extended to nulliparous women. Our hypothesis, that in-utero exposed women have higher hazards of menopause, was not confirmed by our results. Previous studies have shown results both similar and dissimilar to ours, and the method of analysis may have played a role in this. Results similar to ours were observed in a large dataset (n ¼ 22,165), with 30% postmenopausal women and 36% in-utero exposure. 20 The authors censored participants who were postmenopausal due to surgery, just as we have done in our analysis, and found that inutero exposure was not associated with earlier menopause (HR 1.02, 95% CI 0.97-1.7). Another study (n ¼ 4,025) with 37.0% postmenopausal women and 14.8% in-utero exposure has shown an effect on age at menopause (HR 1.21, 95% CI 1.02-1.43). 21 In this study, in-utero exposed women who did not smoke had higher hazards of menopause (HR 1.38, 95% CI 1.10-1.74) compared with the smokers (HR 1.03, 95% CI 0.81-1.31). However, this study was performed in a cohort in which 80% of the women were prenatally exposed to diethylstilbestrol (DES). DES is known for its reductive influence on the development competence of primordial follicles. 22 Therefore, these results might be limited to this specific prenatal DES-exposed population.
In the study of Tawfik et al, 1,001 women were analyzed, of whom 3.8% were postmenopausal and 40% were exposed in inutero. 23 The authors used logistic regression instead of Cox regression, differently from the other studies previously described above. Participants who were smokers and were also exposed to cigarette smoke in-utero had a higher risk of reaching menopause earlier (OR 3.4, 95% CI 1.1-10.3) compared to women who were nonsmokers and who had not been exposed in-utero. Participants who were smokers but were not exposed in-utero had a higher risk of reaching menopause earlier (OR 2.8, 95% CI 0.9-9.0). Participants who were nonsmokers but were exposed in-utero also had a higher risk of reaching menopause earlier (OR 2.7, 95% CI 0.8-9.4). In their analyses, the authors controlled for age of the participants, and since censoring was not an option with the logistic regression model, they excluded women who used HT or had ovarian or 24 When censoring, the analysis takes into consideration that up to the point that participants started using HT or had surgery, participants were still premenopausal and that is important information to include in the analysis. We consider that excluding these women introduces bias, resulting in overestimation of the risk.
Despite the negative effect that smoking has on age at menopause for smokers themselves, the same effect was not observed for women who were only in-utero exposed. One explanation for this may be the strongly programmed mechanism that determines age at menopause. This evidence comes from studies in which women who had unilateral oophorectomy, despite losing half of their ovarian reserve, reached menopause only 1 year earlier. 25, 26 Some studies suggest compensatory growth of the remaining ovary. 27 This indicates that there could be other determinants for the onset of menopause in addition to the size of the follicle pool. Van Asselt et al 28 argue that the capacity of remaining follicles to produce estrogens can be relevant as well for the onset of menopause. Another explanation might be the existence of counterbalancing protective mechanisms such as recruitment in wave-like fashion of less oocytes per cycles 29 or longer cycle lengths so that the total number of ovulations in a lifetime is shortened, 30 supported by studies that showed an earlier age at menopause for mothers of dizygotic twins compared with control mothers. 31, 32 Germline stem cells in adult human ovaries, which could be activated postnatally under specific circumstances, 33 could be another possibility but robust human data are necessary to support this hypothesis.
34,35

CONCLUSIONS
Our results indicate that in-utero smoke exposure is not associated with earlier menopause, though smoking of participants is. There was an interaction observed between inutero smoke exposure and pack years of participants, that is, the effect of in-utero smoke exposure was modified by the smoking habits of the participants themselves. Despite the effect of adult active smoking on age at menopause and the significant reduction of the follicle pool associated with inutero smoke exposure shown in experimental studies, our epidemiological study does not support similar mechanisms for in-utero exposed women who are not smokers themselves. Counterbalancing protective mechanisms may play an important role to maintain the predetermined age at menopause.
